SummaryNew ligands for a variety of biological targets can be selected from biological or synthetic combinatorial peptide libraries. The use of different libraries to select novel peptides with potential therapeutic applications is reviewed. The possible combination of molecular diversity provided by combinatorial libraries and a rational approach derived from computational modeling is also considered. Advantages and disadvantages of different approaches are compared. Possible strategies to bypass loss of peptide bioactivity in the transition from ligand selection to in vivo use are discussed
The construction of new and increasingly diverse libraries, as well as the implementation of more po...
Ligands based on bicyclic peptides can combine favourable properties of antibodies (good binding aff...
From their early roots in natural products, peptides now represent an expanding class of novel drugs...
New ligands for a variety of biological targets can be selected from biological or synthetic combina...
Polypeptide libraries cast a broad net for defining enzyme and binding protein specificities. In add...
Combinatorial screening methodology has been employed to select new affinity specific ligands to bil...
The case for peptide-based drugs is compelling. Due to their chemical, physical and conformational d...
Combinatorial chemistry and biology have become popular methods for the identification of bio-active...
The design, synthesis and screening of diversity-oriented peptide libraries using a “libraries from ...
Monoclonal antibodies have been successfully utilized as cancer-targeting therapeutics and diagnosti...
Although combinatorial libraries owe their inception to applications in peptide and bacteriophage li...
Peptides are used as synthetically available and easily derivatizable scaffold upon which it is poss...
Combinatorial chemistry represents an efficient strategy to discover new bioactives molecules. In th...
All living organisms have their own arsenal of peptides that are responsible for vital biological fu...
After many years of stagnation, peptide therapeutics once again became the focus of innovative drug ...
The construction of new and increasingly diverse libraries, as well as the implementation of more po...
Ligands based on bicyclic peptides can combine favourable properties of antibodies (good binding aff...
From their early roots in natural products, peptides now represent an expanding class of novel drugs...
New ligands for a variety of biological targets can be selected from biological or synthetic combina...
Polypeptide libraries cast a broad net for defining enzyme and binding protein specificities. In add...
Combinatorial screening methodology has been employed to select new affinity specific ligands to bil...
The case for peptide-based drugs is compelling. Due to their chemical, physical and conformational d...
Combinatorial chemistry and biology have become popular methods for the identification of bio-active...
The design, synthesis and screening of diversity-oriented peptide libraries using a “libraries from ...
Monoclonal antibodies have been successfully utilized as cancer-targeting therapeutics and diagnosti...
Although combinatorial libraries owe their inception to applications in peptide and bacteriophage li...
Peptides are used as synthetically available and easily derivatizable scaffold upon which it is poss...
Combinatorial chemistry represents an efficient strategy to discover new bioactives molecules. In th...
All living organisms have their own arsenal of peptides that are responsible for vital biological fu...
After many years of stagnation, peptide therapeutics once again became the focus of innovative drug ...
The construction of new and increasingly diverse libraries, as well as the implementation of more po...
Ligands based on bicyclic peptides can combine favourable properties of antibodies (good binding aff...
From their early roots in natural products, peptides now represent an expanding class of novel drugs...